Anna H. Chen
Principal @ Frazier Life Sciences
San Diego, United States
Anna H. Chen is a Series A investor at Frazier Life Sciences in San Diego focused on Therapeutics and Biotechnology. Anna H. Chen
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Anna H. Chen invests in
Stages Anna H. Chen invests in
Countries Anna H. Chen invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Therapeutics 2 (100%)
- Biotechnology 2 (100%)
- Health Care 1 (50%)
Stage
- Series A 1 (50%)
- Series D 1 (50%)
Country
- Switzerland 1 (50%)
- United States 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions. | $200M / Series A / Jan 09, 2026 | ||
| Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases. | $181.4M / Series D / Nov 12, 2024 |
Co-Investors
About Frazier Life Sciences
Frazier Life Sciences is a healthcare investment firm that focuses on companies developing novel therapeutics, guiding them from formation to scaling. It engages in early stage venture, late stage venture, private equity, and seed investments, demonstrating a broad commitment to healthcare innovation.
Frazier Life Sciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anna H. Chen
Principal
|
|||
Jamie Brush
General Partner and Portfolio Manager
|
|||
Kevin Li
Partner
|
|||
Lauren Mifflin
Vice President of Company Creation
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Anna H. Chen invest in?
Anna H. Chen invests primarily in Therapeutics, Biotechnology and Health Care startups, most often at Series A and Series D stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Anna H. Chen?
Public channels for Anna H. Chen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Anna H. Chen last invest?
The most recent investment recorded for Anna H. Chen closed in Jan 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
